Week 5 Knowledge

12345678910111213141516171819202122232425
Across
  1. 3. narrow therapeutic index medication requiring regular blood levels
  2. 6. high-potency antipsychotic associated with EPS risk
  3. 9. first-line medications for chronic generalized anxiety
  4. 10. high-risk benzo in COPD and older adults
  5. 11. antidepressant class that requires tyramine-restricted diet
  6. 12. benzo used for alcohol withdrawal and seizures
  7. 13. restlessness and inability to sit still from antipsychotics
  8. 15. mood stabilizer associated with liver toxicity and thrombocytopenia
  9. 18. malignant syndrome rare but life-threatening reaction with hyperthermia and rigidity from FGAs
  10. 20. mood stabilizer that can cause bone marrow suppression
  11. 21. johns wort herbal supplement that increases serotonin syndrome risk
  12. 22. sleep intervention recommended before medications
  13. 23. toxicity sign for lithium that must be reported immediately
  14. 25. benzo used for rapid procedural sedation
Down
  1. 1. benzo used short-term for muscle spasm and spasticity
  2. 2. non-benzodiazepine anxiolytic with delayed onset and no dependence risk
  3. 4. antidepressant with least sexual side effects
  4. 5. dyskinesia involuntary tongue and lip movements after long-term antipsychotic use
  5. 7. contraception teaching is important for this teratogenic mood stabilizer
  6. 8. anticonvulsant also used as a mood stabilizer that can cause SJS rash
  7. 14. sedative-hypnotic that may cause sleepwalking or amnesia
  8. 16. antipsychotic requiring ANC monitoring due to agranulocytosis risk
  9. 17. mood stabilizer that requires serum level monitoring and consistent salt intake
  10. 19. dystonia acute severe muscle spasms shortly after starting antipsychotics
  11. 24. two-week washout required before starting an SSRI after this antidepressant